Comparative profiling of immune genes improves the prognoses of lower grade gliomas

OBJECTIVE: Lower grade gliomas (LGGs), classified as World Health Organization (WHO) grade II and grade III gliomas, comprise a heterogeneous group with a median survival time ranging from 4–13 years. Accurate prediction of the survival times of LGGs remains a major challenge in clinical practice. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiliang, Cheng, Wen, Zhao, Zheng, Wang, Zheng, Zhang, Chuanbao, Li, Guanzhang, Wu, Anhua, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088193/
https://www.ncbi.nlm.nih.gov/pubmed/34623790
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088193/
https://www.ncbi.nlm.nih.gov/pubmed/34623790
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0173

Ejemplares similares